Felipe A. Martínez
Universidad Nacional de Córdoba(AR)Instituto Médico DAMIC(AR)Mayo Clinic in Arizona(US)Cordoba University(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer
Most-Cited Works
- → Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction(2019)6,600 cited
- → Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction(2003)4,882 cited
- → Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction(2022)2,473 cited
- → Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction(2019)2,275 cited
- → Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization(2012)865 cited
- → SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials(2022)846 cited